Uromigos Live 2024 Radioligands Part 1: SPLASH Results from ESMO 2024

#UromigosLive24: Radioligands Part 3: UpFront PSMA Results from ESMO 2024Подробнее

Radioligands: Uromigos Live 2024Подробнее

Uromigos Live 2024 Highlights: The Evolving Role of ADT in Prostate CancerПодробнее

SPLASH Trial Results Reinforce Benefits of RLT for mCRPC After Progression on ARPIПодробнее

Uromigos Live 2023: Dr. Mike Morris on Radioligands in Prostate CancerПодробнее

Uromigos Live 2024 Front-Line Therapy in Papillary Renal Cancer Part 1: SUNNIFORECAST DiscussionПодробнее

ESMO 2024 Social Media Report by LucidQuestПодробнее

Uromigos Live & Unplugged 2024 is almost here!Подробнее

ESMO 2024 special: Results of interim analysis of SunRISe-4Подробнее

Dr. Rana McKay on Upcoming Prostate Cancer ESMO Data at The Uromigos: Live & UnpluggedПодробнее

Peri-operative Therapy in Urothelial Carcinoma: Uromigos Live 2024Подробнее

The Uromigos Live: Perioperative Therapy in RCCПодробнее

The Uromigos Definition of Oligometastatic: Uromigos Live 2024Подробнее

ESMO 2024 Lessons in Gynecologic Oncology: Episode 1Подробнее